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1. Introduction 
When transcription of cytoplasmic polyhedrosis 
virus (CPV), containing double-stranded RNA and its 
transcriptase, is carried out in vitro in the presence of 
a methyl-donor S-adenosylmethionine, the synthesized 
messenger RNA carries methylated nucleotides at the 
?-terminus in an unusual form [ 1,2]. As such an odd 
structure seems to be related to the function of mRNA, 
we decided to investigate whether other viral mRNA 
also contains an unusual terminal structure. Thus, the 
in vitro transcription of vaccinia virus, which contains 
double-stranded DNA and transcriptase [3,4], was 
studied. Addition of S-adenosylmethionine to the 
reaction mixture caused synthesis of the methylated 
mRNA. The methylation was restricted to the 5’- 
terminal part, where an unusual structure like that in 
CPV was detected, namely the 5’-terminal nucleotide 
is methylated at the 2’-position of ribose and its 5’- 
phosphate is blocked by 7-methylguanylic acid with a 
pyrophosphate linkage. 
2. Materials and methods 
Vaccinia virus cultured in baby hamster kidney 
cells was collected as described in ref. [5]. Crude virus 
preparation suspended in 0.02 M Tris-HCl buffer (pH 
7.8) containing 0.1 M NaCl and 5 mM EDTA was 
homogenized with the same volume of difluorodi- 
chloromethane (Daiflon, Daikin Co.) [6]. The emul- 
sion was centrifuged to separate the organic solvent. 
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These treatments were effective in extracting the 
activities of RNA polymerase and methylase contained 
in the .virion. The virus was then purified by banding 
in a density gradient of CsCl. The details will be pub- 
lished elsewhere. 
The in vitro RNA synthesis was carried out with 
the Daiflon-treated vaccinia virus under the conditions 
employed by Kates and Beeson [3] with the addition 
of SAM in the final concentration of 40 pmol/ml (for 
labelling, [methyl-3 H] SAM (125 &i/O.01 84 PM) was 
added). 
Methods for analysis of the terminal oligonucleo- 
tides were published previously [2,7,8]. 
3. Results and discussion 
The RNA synthesis by vaccinia virions was performed 
in the reaction mixture according to Kates and Beeson 
[3]. If we added 0.3 M SAM to the reaction mixture, 
RNA synthesis was barely stimulated. It is similar to 
the situation with in vitro synthesis of reovirus mRNA 
in the presence of SAM, although synthesis of CPV 
mRNA was greatly stimulated by SAM [ 11. However, 
a small amount of methyl-3 H in SAM was incorporated 
into the synthesized mRNA in every case. Vaccinia 
virus mRNA was synthesized for 12 hr in a reaction 
mixture containing [methyl-3 H] SAM and [ 14C] UTP. 
It was purified by passing through a Sephadex G-l 00 
column to separate the mRNA from substrates, and 
centrifuged in a density gradient of 5 to 30% glycerol. 
The size of the synthesized RNA ranged from 7s to 
14s (peak is about 11 S). This is the same as the mRNA 
synthesized in the absence of SAM by Kates and 
Beeson [3]. Vaccinia virus mRNA consists of various 
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Fig.1. Sedimentation pattern of vaccinia virus mRNA. mRNA 
was synthesized with [ r 4 C] UTP (10 r.0, 0.168 Ctmol/ml) and 
[methyl-3 H] SAM (125 PCi, 0.00184 Irmol/ml) in the medium 
for in vitro transcription at 32°C for 12 hr. After virus par- 
ticles were centrifuged off, mRNA in the supernatant was 
recovered by Sephadex (G-100) column chromatography and 
by precipitation with ethanol adding carrier ribosomal RNA. 
mRNA was then centrifuged in the linear gradient of 5-30% 
glycerol in 0.02 M Tri-HC1 buffer (pH 7.8) containing 0.1 M 
NaCl and 0.005 M EDTA using a Beckman-Spinco ultra- 
centrifuge L2 and rotor SW 41 at 28000 rev/min for 16 hr at 5°C 
molecular species having different sizes, which were 
transcribed from different cistrons. As shown in fig. 1, 
the radioactivity of [methyL3 H] is distributed in the 
same area as the [ 14C]uridine, which shows a synthe- 
sized RNA. The ratio of 3H/‘4C, however, decreased 
with increase of the size of RNA. In the fractions 
around the peak the incorporated [methyL3 H] was 
calculated as about 1.3 mol per mRNA molecule, and 
this value was almost constant throughout the size 
range of the synthesized RNA. This strongly suggests 
that the same number of methyl residues is incorpo- 
rated at definite sites in every mRNA molecule. 
The [methyL3 H] labeled RNA was then hydrolysed 
by alkali, and the digest was applied on a DEAE-urea 
column. Only one major radioactive peak appeared at 
the position of -5 charge (or tetranucleoside tetra- 
phosphates (fig.2a)). If it is a tetranucleotide, the 
preceeding three nucleosides should be methylated at 
the 2’-position of the ribose moiety. When the [methyl- 
0 
40 60 
oct~on number 
Fig.2. DEAE-urea column chromatography of hydrolysed 
[methyl-a H] labeled vaccinia virus mRNA. (a) Alkaline digest. 
(b) nuclease digest. Digests were chromatographed 
pancreatic ribonuclease digest of ribosomal RNA included 
as a marker. Ehrtion was carried out with a linear gradient of 
NaCl from 0.05 M (50 ml) to 0.4 M (50 ml) in 7 M urea- 
0.02 M Tris-HCI (pH 8.2). Roman numerals over peaks indicate 
the chain length of nucleotides, and numerals in parentheses 
1 labeled RNA was hydrolysed by Penicillium 
nuclease, which splits polynucleotide into 5’-nucleotides 
including a 2’0methyl nucleotide, the radioactivity 
in the digest behaved as one major peak at -2 charge 
(or mononucleoside monophosphate) (tig.2b). This 
corresponds to the mixture of pNm (2’0methyl 
nucleoside-5’-phosphate). However, if the 5’4erminal 
is blocked as shr ‘n in CPV mRNA [2], XppNm will 
also be contained in this fraction. 
Paper electrophoresis of the Penicillium nuclease 
digest showed one radioactive peak near pG (fig.3a). 
Even after this radioactive component was treated with 
phosphomonoesterase, the electrophoretic pattern did 
not change. The phosphate should be blocked as 
XppNm; this component, therefore, is not pG or pGm. 
The radioactive nucleotide in the Penicillium nucle- 
ase digest was then hydrolysed with venom phospho- 
diesterase. The electrophoretic pattern of the hydro- 
lysate revealed three components as shown in fig. 3b. 
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Fig.3. Paper electrophoresis of the terminal oligonucleotide 
and its phosphodiesterase digest. (a) [methyl-’ H] labeled 
vaccinia virus mRNA was digested by PeniciIlium nuclease, in 
which the conditions were the same as in ref. [ 81. The digest 
was paper electrophoresed on Whatman 3MM paper in 5% 
acetic acid-morpholine buffer (pH 3.5) at 35 V/cm for 70 
min. The radioactivity in each km-piece was counted in 5 ml 
of PPO and POPOP-containing toluene. When the sample was 
digested further with phosphomonoesterase (see [S] ), a 
quite similar electrophoregram was obtained. This means that 
the phosphate groups in the sample oligonucleotide are protect- 
ed from phosphomonoesterase. (b) Phosphodiesterase digest 
of the oligonucleotide recovered from (a). The [ ’ H] labeled 
oligonucleotide in (a) was digested further by venom phos- 
phodiesterase (conditions were the same to ref. [ 81). Paper 
electrophoresis was carried out as in (a). 
The ratio of 3 H in components I, II and III was approx. 
5/2/3 in the mean of two experiments. The component 
I is hydrolysed further with phosphomonoesterase and 
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Fig.4. Paper electrophoresis of the phosphomonoesterase 
digest of three components in fig. 3b. (a) (b) and (c) are the 
phosphomonoesterase digest (conditions are written in ref. 
[ 81 of the components I, II and III respectively. Paper electro- 
phoresis was carried out as in fig. 3a 42 V/cm for 70 min, (b) 
35 V/cm for 140 min, (c) 35 V/cm for 140 min. 
electrophoresed again (figAa). The [methyL3H] count 
was found to overlap perfectly the ultraviolet absorp- 
tion of the added authentic 7-methylguanosine. This 
was confirmed also by two-dimensional paper chroma- 
tography as shown in fig. 5. Since the component I 
has a cis-diol (at the 2’- and 3’-positions-details will 
be published elsewhere), it is considered to be 5’- 
phosphorylated 7-methylguanosine (pm’ G) as found 
in the similar digest of CPV mRNA (Furuichi and 
Miura [2]). The component II was identified as 2’- 
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Fig.5 Identification of the component I in fig. 4a with 7- 
methylguanosine by two-dimensional paper chromatography. 
First dimension: n-butanollacetic acid/H, 0, 5/l/4. Second 
dimension: ethylacetate/pyridinelH,O, 75/25/165. Ultraviole 
spots of the added standards m’ G and SAM and other parts 
were cut out, added to 5 ml of PPO- and POPOP-containing 
toluene and counted in a scintillation spectrometer. A radio- 
active spot is represented by dots. 
0-methyladenosine-5’-phosphate (pAm) by co-running 
with the authentic pAm in paper electrophoresis and 
two-dimensional paper chromatography. It was 
confirmed by phosphomonoesterase treatment, which 
yielded Am (Am was compared with the authentic 
material as shown in fig. 4b). The component III was 
identified as 2’-0-methylguanosine-5’-phosphate, 
pGm, by methods similar to those used for pAm (fig. 
4c). 
As written above, the phosphates of the 5’-terminal 
nucleotide in vaccinia virus mRNA are blocked by 
some material, and three components, that is 7-methyl- 
5’-guanylic acid, 2’-O-methyl-5’-guanylic acid, and 
2’-O-methyl-5’-adenylic acid, are obtained from the 
5’terminal part. Since the 5’-terminal nucleotide of 
CPV mRNA is a 2’-0-methylated adenylic acid, and 
its 5’-phosphates are blocked by 7-methyl-5’-guanylic 
acid with pyrophosphate linkage [2], the vaccinia 
virus mRNA would be blocked at the 5’-terminal in a 
similar manner. If components I, II and III were derived 
from a continuing sequence as m7Gs’pps’AmpGmpNp 
--- (or m7Gs’ppS’GmpAmpNp---) at the 5’- 
terminal, Penicillium nuclease digestion must yield 
m’ Gs ‘pps ‘Am and pGm (or m’ Gs ‘pp’ ‘Gm and pAm) 
as the [methy13H] labeled components. m7Gs’pps’Am 
and pGm (or m’ Gs ‘pp’ ‘Gm and pAm) carry -2 charge 
in DEAE-urea column chromatography (fig.2b), and 
have similar mobilities near pG in paper electrophoresis 
(fig.3a). However, this is not likely the case, since 
no pAm and pGm were found in the Penicillium nucle- 
ase digest. And the molar ratio of pm’G/pAm/pGm in 
the phosphodiesterase digest was not l/l/l, but 51213; 
in any case the radioactivity of component I corresponds 
to the sum of components II and III. If there are two 
kinds of mRNA for vaccinia virus, whose 5’-terminal 
structures are m7Gs’pps’AmpNp--- and m7Gs’ppS’ 
GmpNp---, alkali digestion must yield m7G’s’pps’ 
AmpNp and m7G”‘ppS’GmpNp as the [methy13H] 
labeled components (m’ G’ means a change of m’G 
caused by alkali). Since the imidazole ring of 7 methyl- 
guanosine decomposes by alkali treatment to lose a 
plus charge, m7G’s’pps’AmpNp and m7G’s’pps’ 
GmpNp would have -5 charge. Here, if ratio of the 
amounts of m7Gs’pps’Am and m7Gs’pps’Gm is 2:3, 
all the experimental results can be explained without 
inconsistency. In fact the 3 H labeled oligonucleotides 
in the Penicillium nuclease digest were separated into 
two components by the Dowex-1 column chromato- 
graphy. 
The transcript from polycistronic gene may have 
at least two kinds of starting as shown already for 
phage transcription [9]. Kates and Beeson [3] stated 
that -Y-~~P-ATP and very little amount or -Y-~~P-CTP 
are incorporated into vaccinia mRNA as its 5’-terminal 
nucleotide. However, this is the in vitro transcription 
without SAM. Even in the in vitro transcription, the 
presence of SAM may change the situation. 
These results lead us to the conclusion that : (1) the 
RNAs transcribed from vaccinia virus in the presence of 
SAM are methylated at the 2’-position of the 5’-ter- 
minal nucleotide; (2) their 5’-terminal phosphates are 
blocked by ‘I-methylguanosine-5’-phosphate hrough a 
pyrophosphate linkage; (3) 3/5 of the mRNA molecules 
carry 2’-O-methyl guanylic acid as the 5’-terminal 
nucleotide and the rest 2’-O-methyl adenylic acid. 
Thus the 5’terminal structures of the mRNA trans- 
cribed from vaccinia virus in the presence of SAM in 
vitro are summarized in the following two formulas: 
m7GS’pps’Gm-and m7Gs’pps’An-. These modified 
structures at the 5’-terminal of vaccinia virus mRNA 
are similar to the mRNA of CPV [2], except for the 
number of phosphates. That the blocking at the 5’- 
terminal phosphates by 7-methylguanosine as well as 
the methylation at the 2’-position of the terminal 
nucleotide in a mRNA molecule are common for these 
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viral mRNA’s, suggests that these abnormal structures 
are necessary for the function and/or the control of 
metabolism of mRNA. 
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